We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BTAI market cap is 15.78M. The company's latest EPS is USD -4.1885 and P/E is -0.09.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 341k | 376k | 582k | 1.1M | 214k |
| Operating Income | -48.3M | -19.88M | -24.16M | -17.3M | -15.29M |
| Net Income | -50.49M | -22.26M | -26.79M | -8.3M | -13.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 375k | 1.38M |
| Operating Income | -33.6M | -82.3M | -106.94M | -159.65M | -171.78M |
| Net Income | -32.97M | -82.17M | -106.93M | -165.76M | -179.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 100.45M | 73.7M | 82.32M | 65.44M | 48.89M |
| Total Liabilities | 141.06M | 130.21M | 154.69M | 139.74M | 134.53M |
| Total Equity | -40.61M | -56.51M | -72.36M | -74.3M | -85.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.39M | 219.94M | 239.44M | 205.85M | 73.7M |
| Total Liabilities | 9.5M | 13.24M | 17.77M | 129.08M | 130.21M |
| Total Equity | 26.9M | 206.7M | 221.67M | 76.78M | -56.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -128.14M | -155.01M | -17.71M | -40.88M | -57.22M |
| Investing | -20k | -20k | N/A | N/A | N/A |
| Financing | 24.4M | 26.52M | 26.63M | 31.93M | 32.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.28M | -66.35M | -82.15M | -135.34M | -155.01M |
| Investing | -870k | -316k | -445k | -139k | -20k |
| Financing | 18.01M | 247.36M | 102.45M | 96.24M | 26.52M |
| Market Cap | 15.78M |
| Price to Earnings Ratio | -0.09 |
| Price to Sales Ratio | 11.76 |
| Price to Cash Ratio | 0.25 |
| Price to Book Ratio | -0.29 |
| Dividend Yield | - |
| Shares Outstanding | 42.75M |
| Average Volume (1 week) | 1.31M |
| Average Volume (1 Month) | 1M |
| 52 Week Change | -87.32% |
| 52 Week High | 4.17 |
| 52 Week Low | 0.3013 |
| Spread (Intraday) | 0.03 (7.5%) |
| Company Name | BioXcel Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bioxceltherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
